Wanbury share news, announcements and annual reports
NSE: WANBURYBSE: 524212Pharmaceuticals & BiotechnologySmall Cap
Wanbury Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1992 on BSE, Jan 2007 on NSE
Last close ₹189.21up ₹7.28 (4.00%)BSE ₹189.75
Share price at the NSE close on 30 Oct 2026. Previous close ₹181.93.
30 Oct: open ₹180.00, high ₹192.00, low ₹175.98
52-week range of traded prices to 30 Oct 2026
₹161.50Low, 27 Jan 2026₹358.85High, 15 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹662 Cr1,555th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.84
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.58
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 54.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 23.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.49
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,32,73737.4% delivered
Wanbury share news and announcements
572 announcements, routine notices left out, newest first. Page 9 of 12.
Oct 2015
1 Oct · Disclosure of Voting Pattern - Clause 35A
Sep 2015
28 Sep · Board meeting
Aug 2015
Jul 2015
May 2015
Apr 2015
Mar 2015
25 Mar · Disclosure of Voting Pattern - Clause 35A
4 Mar · Corporate action
Company has fixed Book Closure from March 16, 2015 to March 23, 2015 for the purpose of Annual General Meeting.
Feb 2015
Jan 2015
29 Jan · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2014.20 Jan · Management
Export Import Bank of India has withdrawn nomination of Mr. Manish Joshi from the directorship of the Company.
Dec 2014
Nov 2014
14 Nov · Board meeting
Inter alia, to consider and take on record the Audited Financial Results of the Company for the financial year 2013-14 i.e. from April 1, 2013 to September 30, 2014.
Oct 2014
27 Oct · Strikes/Lockouts/Disturbances
Aug 2014
Jul 2014
22 Jul · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the fifth quarter and fifteen months ended June 30, 2014.
May 2014
12 May · Results
Mar 2014
24 Mar · Extension of Financial Year
Company' Current Accounting Year has been extended and now it will be for 18 months from April 01, 2013 to September 30, 2014 instead of 12 months from April 01, 2013 to March 31, 2014. Therefore the Company will submit to Stock Exchange Unaudited Financial Results for the quarter ending on March 31, 2014 & June 30, 2014 and Annual Audited Financial Results for 18 months from April 01, 2013 to September 30, 2014. Further, the Company has received an approval from the Office of Registrar of Companies, Ministry of Corporate Affairs, Govt. of India on March 21, 2014.
Feb 2014
11 Feb · Results
Jan 2014
28 Jan · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2013.
Nov 2013
14 Nov · Results
7 Nov · Updates
Cantabria Pharma S.L., Spain, subsidiary of the Company has filed petition for voluntary insolvency in the Commercial Courts of Madrid, Spain on November 04, 2013.
Oct 2013
18 Oct · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2013.
Sep 2013
27 Sep · Updates
Company's manufacturing facilities at Patalganga and Tanaku have been classified as acceptable by the Department of Health & Human Services, Public Health Service, Food and Drug Administration, U.S.A. (US FDA).19 Sep · Corporate action
Company has fixed Book Closure from September 28, 2013 to September 30, 2013 (both days inclusive) for the purpose of taking of a record of its shareholders.
Aug 2013
7 Aug · Business
Pursuant to the provisions of Companies Act, 1956; Corporate Debt Restructuring approved by the Bankers of the Company and approval of the Shareholders of the Company through Postal Ballot Resolution, the Company has on August 05, 2013 allotted 25,90,000 (Twenty Five Lac Ninety Thousand) Equity Shares at a price of Rs. 37.50 (Rupees Thirty Seven and Paisa Fifty only) (Face Value Rs. 10/- and Premium Rs. 27.50/-) per equity share to Expert Chemicals (I) Pvt. Limited, a promoter group Company.
Jul 2013
23 Jul · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter ended June 30, 2013.3 Jul · Updates
Major regulatory changes resulting in continuous and severe price cuts has adversely affected revenues and profitability of Cantabria Pharma S. L., a subsidiary of the Company (Wanbury Limited). Therefore, Cantabria has filed a "Pre Insolvency Petition" in the Court of Madrid, Spain.
Jun 2013
May 2013
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2013 have approved the following: (1) Appointment of Mr.S.K.Bhattacharyya, former Managing Director of State Bank of India as an Additional Director; (2) Appointment of Mr.Manish Joshi in place of Mr.P.R.Dalal as Exim Bank nominee; and (3) Resignation of Mr.Sundaresh Bhat as CFO of the Company.16 May · Change in Financial Year
The Board of Directors of the Company has decided to annual the extension of Company s Current Accounting Year. Now the company s financial year will be period of 12 months from 1st April, 2012 to 31st March, 2013. Therefore the Company will submit to Stock Exchange Annual Audited Financial Results for 12 months from 1st April, 2012 to 31st March, 2013. Intimation to this effect has already been given to the Office of Registrar of Companies, Ministry of Corporate Affairs, Govt. of India16 May · Board meeting
Inter alia, to consider and take on record the Audited Financial Results of the Company for the financial year 2012-13.
Mar 2013
25 Mar · Extension of Financial Year
Company's Current Accounting Year has been extended and now it will be for 18 months from April 01, 2012 to September 30, 2013 instead of 12 months from April 01, 2012 to March 31, 2013.Therefore the Company will submit to Stock Exchange Unaudited Financial Results for the quarter ending on March 31, 2013 & June 30, 2013 and Annual Audited Financial Results for 18 months from April 01, 2012 to September 30, 2013.The approval received from the Office of Registrar of Companies, Ministry of Corporate Affairs, Govt. of India on March 14, 2013.
Feb 2013